- Home
- LRMR vs ZTEK Comparison
LRMR vs ZTEK Comparison
Compare LRMR & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LRMR
- ZTEK
- Stock Information
- Founded
- LRMR N/A
- ZTEK 2008
- Country
- LRMR United States
- ZTEK Canada
- Employees
- LRMR N/A
- ZTEK N/A
- Industry
- LRMR Biotechnology: Pharmaceutical Preparations
- ZTEK Major Chemicals
- Sector
- LRMR Health Care
- ZTEK Industrials
- Exchange
- LRMR Nasdaq
- ZTEK Nasdaq
- Market Cap
- LRMR 171.6M
- ZTEK 165.9M
- IPO Year
- LRMR N/A
- ZTEK N/A
- Fundamental
- Price
- LRMR $2.67
- ZTEK $1.33
- Analyst Decision
- LRMR Strong Buy
- ZTEK
- Analyst Count
- LRMR 7
- ZTEK 0
- Target Price
- LRMR $18.86
- ZTEK N/A
- AVG Volume (30 Days)
- LRMR 1.1M
- ZTEK 29.1K
- Earning Date
- LRMR 08-06-2025
- ZTEK 08-13-2025
- Dividend Yield
- LRMR N/A
- ZTEK N/A
- EPS Growth
- LRMR N/A
- ZTEK N/A
- EPS
- LRMR N/A
- ZTEK N/A
- Revenue
- LRMR N/A
- ZTEK $44,936.00
- Revenue This Year
- LRMR N/A
- ZTEK N/A
- Revenue Next Year
- LRMR N/A
- ZTEK N/A
- P/E Ratio
- LRMR N/A
- ZTEK N/A
- Revenue Growth
- LRMR N/A
- ZTEK 92.38
- 52 Week Low
- LRMR $1.61
- ZTEK $0.50
- 52 Week High
- LRMR $11.20
- ZTEK $1.84
- Technical
- Relative Strength Index (RSI)
- LRMR 56.20
- ZTEK 36.79
- Support Level
- LRMR $2.60
- ZTEK $1.39
- Resistance Level
- LRMR $3.02
- ZTEK $1.55
- Average True Range (ATR)
- LRMR 0.25
- ZTEK 0.09
- MACD
- LRMR 0.01
- ZTEK -0.02
- Stochastic Oscillator
- LRMR 51.35
- ZTEK 2.04
About LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.
About ZTEK Zentek Ltd.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.